Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | KDM1A | O60341 | 7/20 | 0.38 |
| ▸ | KDR | P35968 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 9/20 | 0.37 |
| ▸ | MAOA | P21397 | 7/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7980259 | 0.80 | RAB9A (0.61) | RAB9ANPC1ALOX12NPSR1MEN1 | |
| SCHEMBL20520092 | 0.76 | RAB9A (0.41) | RAB9ANPSR1MEN1MAPK10GFER | |
| SCHEMBL1290463 | 0.71 | KDM1A (0.59) | RAB9AMAPK10KDM1AKDRMAOB | |
| SCHEMBL15355748 | 0.71 | KDM1A (0.59) | RAB9AMAPK10KDM1AKDRMAOB | |
| SCHEMBL1290465 | 0.71 | KDM1A (0.59) | RAB9AMAPK10KDM1AKDRMAOB | |
| SCHEMBL6837492 | 0.70 | RAB9A (0.63) | RAB9ANPC1ALOX12NPSR1MEN1 | |
| Hydrochloric Acid SCHEMBL1290493 | 0.70 | KDM1A (0.57) | RAB9AMAPK10KDM1AKDRMAOB | |
| Hydrochloric Acid SCHEMBL1290494 | 0.70 | KDM1A (0.57) | RAB9AMAPK10KDM1AKDRMAOB | |
| SCHEMBL7000211 | 0.69 | KDM1A (0.48) | CYP2A6KDM1AMAOBMAOACYP2C19 | |
| SCHEMBL7092952 | 0.69 | KDM1A (0.48) | CYP2A6KDM1AMAOBMAOACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180284095-A1 | BIOMARKERS ASSOCIATED WITH LSD1 INHIBITORS AND USES THEREOF | ORYZON GENOMICS SA (ES) | 2018-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180284095-A1 | BIOMARKERS ASSOCIATED WITH LSD1 INHIBITORS AND USES THEREOF | KDM1B, EZH2, DOT1L | RAB9A 3157/4885NPC1 2975/4885ALOX12 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.